18 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Magenta Therapeutics, Inc. MGTA stock increased by 13.55% to $9.05 during Monday's pre-market session. The most recent rating by Goldman Sachs, on Jun 8, is at Buy, with a price target of $15.

• Acasti Pharma, Inc. ACST shares increased by 12.50% to $0.60. The most recent rating by Aegis Capital, on May 6, is at Buy, with a price target of $2.

• Mesoblast, Inc. MESO stock increased by 12.12% to $13.50. The most recent rating by HC Wainwright & Co., on May 28, is at Buy, with a price target of $21.

• resTORbio, Inc. TORC shares rose 10.82% to $2.56. The most recent rating by Evercore ISI Group, on Apr 30, is at Outperform, with a price target of $4.

• Cellectar Biosciences, Inc. CLRB stock increased by 10.63% to $1.56. The most recent rating by Oppenheimer, on Jul 1, is at Outperform, with a price target of $5.

• Lianluo Smart, Inc. LLIT shares rose 10.01% to $0.71.

• Centogene, Inc. CNTG stock moved upwards by 9.38% to $26.80. The most recent rating by Baird, on Apr 24, is at Outperform, with a price target of $20.

• BioCardia, Inc. BCDA shares increased by 8.51% to $2.55.

• So-Young Intl, Inc. SY stock increased by 8.40% to $16. The most recent rating by Canaccord Genuity, on May 19, is at Buy, with a price target of $15.

• Evofem Biosciences, Inc. EVFM stock increased by 7.38% to $3.20. The most recent rating by HC Wainwright & Co., on Jun 9, is at Buy, with a price target of $9.

Losers

• Endologix, Inc. ELGX shares decreased by 47.63% to $0.40 during Monday's pre-market session. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.

• Alterity Therapeutics, Inc. ATHE stock declined 8.76% to $1.46.

• Myos Rens Technology, Inc. MYOS stock declined 5.89% to $1.60.

• Celsion, Inc. CLSN stock decreased by 4.93% to $4.05.

• Citius Pharmaceuticals, Inc. CTXR shares fell 4.92% to $1.16.

• Cocrystal Pharma, Inc. COCP stock fell 4.58% to $1.46. The most recent rating by Noble Capital Markets, on Jun 16, is at Outperform, with a price target of $5.

• 9 Meters Biopharma, Inc. NMTR shares declined 4.35% to $0.61.

• Titan Pharmaceuticals, Inc. TTNP shares declined 3.11% to $0.29.